Clinical Trial Update: Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of an investigational HIV drug in patients failing current antiretroviral therapy, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Investigational drug (NCT00105157)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2010-04-12